» Articles » PMID: 14726171

Appropriate Body-mass Index for Asian Populations and Its Implications for Policy and Intervention Strategies

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2004 Jan 17
PMID 14726171
Citations 4635
Affiliations
Soon will be listed here.
Abstract

A WHO expert consultation addressed the debate about interpretation of recommended body-mass index (BMI) cut-off points for determining overweight and obesity in Asian populations, and considered whether population-specific cut-off points for BMI are necessary. They reviewed scientific evidence that suggests that Asian populations have different associations between BMI, percentage of body fat, and health risks than do European populations. The consultation concluded that the proportion of Asian people with a high risk of type 2 diabetes and cardiovascular disease is substantial at BMIs lower than the existing WHO cut-off point for overweight (> or =25 kg/m2). However, available data do not necessarily indicate a clear BMI cut-off point for all Asians for overweight or obesity. The cut-off point for observed risk varies from 22 kg/m2 to 25 kg/m2 in different Asian populations; for high risk it varies from 26 kg/m2 to 31 kg/m2. No attempt was made, therefore, to redefine cut-off points for each population separately. The consultation also agreed that the WHO BMI cut-off points should be retained as international classifications. The consultation identified further potential public health action points (23.0, 27.5, 32.5, and 37.5 kg/m2) along the continuum of BMI, and proposed methods by which countries could make decisions about the definitions of increased risk for their population.

Citing Articles

Sex differences in the prediction of metabolic abnormalities via body mass index in an Eastern Chinese population.

Gao Y, Jin K, Chen J, Chen B, Guo Y, Lu J Front Nutr. 2025; 12:1491818.

PMID: 40078410 PMC: 11896866. DOI: 10.3389/fnut.2025.1491818.


Associations of essential trace metals with telomere length in general population: a cross-sectional study.

Rong J, Liu Q, Zhang T, Lu Y, Ye Z, Teng K Sci Rep. 2025; 15(1):8387.

PMID: 40069335 PMC: 11897380. DOI: 10.1038/s41598-025-93216-w.


Prevalence of Hypertension and Its Associated Factors Among Patients with Type 2 Diabetes in Southern Afghanistan: A Multi-Center Cross-Sectional Study.

Stanikzai M, Amirzada M, Ishaq N, Kamil K, Anwary Z, Farzad A Diabetes Metab Syndr Obes. 2025; 18:715-725.

PMID: 40066128 PMC: 11892732. DOI: 10.2147/DMSO.S503725.


Unveiling the benefits of Vitamin D3 with SGLT-2 inhibitors for hypertensive obese obstructive sleep apnea patients.

Loh H, Tay S, Koa A, Yong M, Said A, Chai C J Transl Med. 2025; 23(1):296.

PMID: 40055713 PMC: 11889775. DOI: 10.1186/s12967-025-06312-w.


Effect of the 5:2 Diet on Weight Loss and Cardiovascular Disease Risk Factors in Overweight and/or Obesity: A Systematic Review and Meta-Analysis.

Wu C, Chen B, Yu J, Zhang Q, Piao C Int J Endocrinol. 2025; 2025:6658512.

PMID: 40041761 PMC: 11876533. DOI: 10.1155/ije/6658512.